DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Bajaj JS, Heuman DM, Sanyal AJ. , et al.
Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy.
PLoS One 2013;
8 (04) e60042
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.